Polycythemia vera: Difference between revisions
ClaireLewis (talk | contribs) |
ClaireLewis (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Chronic myeloproliferative disorder | *Chronic [[myeloproliferative disorders|myeloproliferative disorder]] | ||
*Abnormal proliferation is seen in all 3 cell lines | *Abnormal proliferation is seen in all 3 cell lines | ||
*Typically in elderly | *Typically in elderly | ||
Line 9: | Line 9: | ||
*Severe burning pain in the hands or feet accompanied by a reddish or bluish coloration of the skin | *Severe burning pain in the hands or feet accompanied by a reddish or bluish coloration of the skin | ||
*Suspected with any combination of the following: <ref>http://emedicine.medscape.com/article/205114-differential</ref> | *Suspected with any combination of the following: <ref>http://emedicine.medscape.com/article/205114-differential</ref> | ||
**Abnormally elevated hemoglobin levels (>18 g/dL in men; 16 g/dL in women) | **Abnormally ''elevated'' hemoglobin levels (>18 g/dL in men; 16 g/dL in women) | ||
**Normal oxygen saturation | **Normal oxygen saturation | ||
**Bleeding complications | **Bleeding complications | ||
Line 18: | Line 18: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*Essential thrombocytosis (ET) | *[[Essential thrombocytosis (ET)]] | ||
*[[Chronic myelogenous leukemia]] (CML) | *[[Chronic myelogenous leukemia]] (CML) | ||
*[[Leukemoid Reaction]] | *[[Leukemoid Reaction]] |
Revision as of 17:37, 1 October 2019
Background
- Chronic myeloproliferative disorder
- Abnormal proliferation is seen in all 3 cell lines
- Typically in elderly
- Can be asymptomatic or symptomatic
- Commonly caused by JAK2 mutation
Clinical Features
- Severe burning pain in the hands or feet accompanied by a reddish or bluish coloration of the skin
- Suspected with any combination of the following: [1]
- Abnormally elevated hemoglobin levels (>18 g/dL in men; 16 g/dL in women)
- Normal oxygen saturation
- Bleeding complications
- Portal vein thrombosis
- Splenomegaly
- Plethora
- Pruritus after bathing
Differential Diagnosis
Evaluation
Workup
- CBC
- Chem 7
- ESR
- EPO decreased
- Bone marrow biopsy sometimes needed
Evaluation[2]
- Criteria 1: All category A
- Criteria 2: First 3 of category A and any 2 of category B
Category A | Category B |
---|---|
Increased RBC Mass (Men >18.5, Women >16.5) | Thrombocytosis (>400,000) |
Normal SPO2 (>92%) | Leukocytosis (>12,000) |
Splenomegaly | Leukocyte Alk Phos >100 |
Vit B12 >900 |
Management
- Phlebotomy with goal hematocrit < 45%[3]
- Patients with severe plethora, with AMS or vascular compromise can be bled vigorously with removal of 500 mL of whole blood rapidly
- Otherwise, gradual phlebotomy of 500-1000 mL over 24 hours is preferred in less emergent cases
- ASA 81mg
- Myelosuppressive agents (hydroxyurea, interferon-α)
Also See
References
- ↑ http://emedicine.medscape.com/article/205114-differential
- ↑ Tefferi, A, et al. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer. 2009; 115(17):3842-7,
- ↑ Marchioli R et al. Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med. 2013; 368(1):22-33.